nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesalazine—PTGS2—adrenal gland cancer	0.814	1	CbGaD
Mesalazine—PPARG—brown adipose tissue—adrenal gland cancer	0.00787	0.342	CbGeAlD
Mesalazine—CHUK—adrenal gland—adrenal gland cancer	0.00225	0.098	CbGeAlD
Mesalazine—Salicylate-sodium—PTGS2—adrenal gland cancer	0.00194	0.275	CrCbGaD
Mesalazine—IKBKB—gonad—adrenal gland cancer	0.00176	0.0764	CbGeAlD
Mesalazine—IKBKB—pituitary gland—adrenal gland cancer	0.00171	0.0745	CbGeAlD
Mesalazine—IKBKB—adrenal gland—adrenal gland cancer	0.00153	0.0666	CbGeAlD
Mesalazine—Olsalazine—PTGS2—adrenal gland cancer	0.00133	0.188	CrCbGaD
Mesalazine—ALOX5—adrenal gland—adrenal gland cancer	0.00127	0.0552	CbGeAlD
Mesalazine—Aminosalicylic Acid—PTGS2—adrenal gland cancer	0.00125	0.177	CrCbGaD
Mesalazine—Diflunisal—PTGS2—adrenal gland cancer	0.00125	0.177	CrCbGaD
Mesalazine—MPO—pituitary gland—adrenal gland cancer	0.0012	0.0523	CbGeAlD
Mesalazine—MPO—adrenal gland—adrenal gland cancer	0.00107	0.0467	CbGeAlD
Mesalazine—PPARG—adrenal gland—adrenal gland cancer	0.000953	0.0414	CbGeAlD
Mesalazine—Salicylic acid—PTGS2—adrenal gland cancer	0.000695	0.0985	CrCbGaD
Mesalazine—PTGS2—adrenal cortex—adrenal gland cancer	0.000675	0.0293	CbGeAlD
Mesalazine—Salicylic acid—ABCB1—adrenal gland cancer	0.000591	0.0838	CrCbGaD
Mesalazine—PTGS1—cardiac atrium—adrenal gland cancer	0.000584	0.0254	CbGeAlD
Mesalazine—PTGS1—pituitary gland—adrenal gland cancer	0.00057	0.0248	CbGeAlD
Mesalazine—PTGS2—pituitary gland—adrenal gland cancer	0.000545	0.0237	CbGeAlD
Mesalazine—PTGS1—adrenal gland—adrenal gland cancer	0.00051	0.0222	CbGeAlD
Mesalazine—PTGS2—adrenal gland—adrenal gland cancer	0.000487	0.0212	CbGeAlD
Mesalazine—CHUK—BDNF signaling pathway—BAD—adrenal gland cancer	0.000334	0.00214	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—CDC42—adrenal gland cancer	0.000333	0.00213	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—PRKACA—adrenal gland cancer	0.000332	0.00212	CbGpPWpGaD
Mesalazine—PPARG—Generic Transcription Pathway—MED12—adrenal gland cancer	0.000327	0.00209	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—PRKACA—adrenal gland cancer	0.000326	0.00209	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling of activated FGFR—BAD—adrenal gland cancer	0.000325	0.00208	CbGpPWpGaD
Mesalazine—CHUK—AGE/RAGE pathway—EGFR—adrenal gland cancer	0.000325	0.00208	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000324	0.00207	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—BAD—adrenal gland cancer	0.000322	0.00206	CbGpPWpGaD
Mesalazine—CHUK—Rac1/Pak1/p38/MMP-2 pathway—EGFR—adrenal gland cancer	0.000321	0.00205	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB4—BAD—adrenal gland cancer	0.00032	0.00205	CbGpPWpGaD
Mesalazine—PPARG—Generic Transcription Pathway—MEN1—adrenal gland cancer	0.000312	0.002	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—MED12—adrenal gland cancer	0.000308	0.00197	CbGpPWpGaD
Mesalazine—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—CTNNB1—adrenal gland cancer	0.000307	0.00196	CbGpPWpGaD
Mesalazine—CHUK—Downstream signal transduction—BAD—adrenal gland cancer	0.000306	0.00195	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR—BAD—adrenal gland cancer	0.000304	0.00194	CbGpPWpGaD
Mesalazine—IKBKB—BDNF signaling pathway—BAD—adrenal gland cancer	0.000303	0.00194	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.000303	0.00194	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB2—BAD—adrenal gland cancer	0.000303	0.00194	CbGpPWpGaD
Mesalazine—CHUK—DAP12 signaling—BAD—adrenal gland cancer	0.000301	0.00193	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—PRKACA—adrenal gland cancer	0.000301	0.00192	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—BAD—adrenal gland cancer	0.000297	0.0019	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—PRKACA—adrenal gland cancer	0.000296	0.00189	CbGpPWpGaD
Mesalazine—IKBKB—AGE/RAGE pathway—EGFR—adrenal gland cancer	0.000295	0.00189	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—BRAF—adrenal gland cancer	0.000293	0.00187	CbGpPWpGaD
Mesalazine—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—EGFR—adrenal gland cancer	0.000291	0.00186	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—RB1—adrenal gland cancer	0.000288	0.00184	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—BAD—adrenal gland cancer	0.000283	0.00181	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—BAD—adrenal gland cancer	0.000283	0.00181	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR in disease—BAD—adrenal gland cancer	0.000283	0.00181	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR—BAD—adrenal gland cancer	0.000281	0.0018	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR in Cancer—BAD—adrenal gland cancer	0.000278	0.00178	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—BAD—adrenal gland cancer	0.000277	0.00177	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR—BRAF—adrenal gland cancer	0.000277	0.00177	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000275	0.00176	CbGpPWpGaD
Mesalazine—PTGS1—Selenium Micronutrient Network—PTGS2—adrenal gland cancer	0.000272	0.00174	CbGpPWpGaD
Mesalazine—CHUK—Rac1/Pak1/p38/MMP-2 pathway—TP53—adrenal gland cancer	0.00027	0.00172	CbGpPWpGaD
Mesalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—BAD—adrenal gland cancer	0.000269	0.00172	CbGpPWpGaD
Mesalazine—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—adrenal gland cancer	0.000269	0.00172	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.000267	0.0017	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—RRM1—adrenal gland cancer	0.000265	0.00169	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—SDHD—adrenal gland cancer	0.000265	0.00169	CbGpPWpGaD
Mesalazine—CHUK—p75(NTR)-mediated signaling—TP53—adrenal gland cancer	0.000264	0.00168	CbGpPWpGaD
Mesalazine—CHUK—Constitutive PI3K/AKT Signaling in Cancer—EGFR—adrenal gland cancer	0.000263	0.00168	CbGpPWpGaD
Mesalazine—CHUK—Immune System—SH3KBP1—adrenal gland cancer	0.000263	0.00168	CbGpPWpGaD
Mesalazine—CHUK—B Cell Activation—BAD—adrenal gland cancer	0.000262	0.00168	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—NR5A1—adrenal gland cancer	0.000262	0.00167	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR in disease—BRAF—adrenal gland cancer	0.000258	0.00165	CbGpPWpGaD
Mesalazine—PTGS2—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	0.000257	0.00164	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—BAD—adrenal gland cancer	0.000257	0.00164	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—SDHB—adrenal gland cancer	0.000255	0.00163	CbGpPWpGaD
Mesalazine—PPARG—Adipogenesis—CTNNB1—adrenal gland cancer	0.000254	0.00163	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—BAD—adrenal gland cancer	0.000251	0.0016	CbGpPWpGaD
Mesalazine—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—TP53—adrenal gland cancer	0.000245	0.00156	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—BRAF—adrenal gland cancer	0.000244	0.00156	CbGpPWpGaD
Mesalazine—CHUK—Disease—SH3KBP1—adrenal gland cancer	0.000243	0.00155	CbGpPWpGaD
Mesalazine—PTGS2—C-MYB transcription factor network—CDKN2A—adrenal gland cancer	0.00024	0.00153	CbGpPWpGaD
Mesalazine—IKBKB—p75(NTR)-mediated signaling—TP53—adrenal gland cancer	0.000239	0.00153	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—SH3KBP1—adrenal gland cancer	0.000238	0.00152	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—BAD—adrenal gland cancer	0.000238	0.00152	CbGpPWpGaD
Mesalazine—CHUK—PI-3K cascade—EGFR—adrenal gland cancer	0.000237	0.00152	CbGpPWpGaD
Mesalazine—CHUK—PI3K/AKT activation—EGFR—adrenal gland cancer	0.000231	0.00148	CbGpPWpGaD
Mesalazine—CHUK—GAB1 signalosome—EGFR—adrenal gland cancer	0.00023	0.00147	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—BRAF—adrenal gland cancer	0.000229	0.00146	CbGpPWpGaD
Mesalazine—CHUK—Disease—ZNRF3—adrenal gland cancer	0.000228	0.00146	CbGpPWpGaD
Mesalazine—CHUK—Apoptosis—TP53—adrenal gland cancer	0.000225	0.00144	CbGpPWpGaD
Mesalazine—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—adrenal gland cancer	0.000224	0.00143	CbGpPWpGaD
Mesalazine—CHUK—BDNF signaling pathway—CTNNB1—adrenal gland cancer	0.00022	0.00141	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	0.000212	0.00136	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—CTNNB1—adrenal gland cancer	0.000212	0.00135	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—RB1—adrenal gland cancer	0.000208	0.00133	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis—TP53—adrenal gland cancer	0.000204	0.00131	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.0002	0.00128	CbGpPWpGaD
Mesalazine—PTGS1—Biological oxidations—POMC—adrenal gland cancer	0.000199	0.00128	CbGpPWpGaD
Mesalazine—IKBKB—BDNF signaling pathway—CTNNB1—adrenal gland cancer	0.000199	0.00127	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—MED12—adrenal gland cancer	0.000198	0.00126	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	0.000196	0.00125	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—BAD—adrenal gland cancer	0.000193	0.00123	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000192	0.00123	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis Modulation and Signaling—TP53—adrenal gland cancer	0.000192	0.00122	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—CDC42—adrenal gland cancer	0.00019	0.00122	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—PRKACA—adrenal gland cancer	0.000186	0.00119	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—GNRHR—adrenal gland cancer	0.000183	0.00117	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—PRKACA—adrenal gland cancer	0.000179	0.00114	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—SDHB—adrenal gland cancer	0.000178	0.00114	CbGpPWpGaD
Mesalazine—CHUK—Signaling by SCF-KIT—EGFR—adrenal gland cancer	0.000177	0.00113	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000177	0.00113	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—BRAF—adrenal gland cancer	0.000176	0.00112	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	0.000175	0.00112	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—BAD—adrenal gland cancer	0.000175	0.00112	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00017	0.00109	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling of activated FGFR—EGFR—adrenal gland cancer	0.00017	0.00108	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—PRKACA—adrenal gland cancer	0.000169	0.00108	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—EGFR—adrenal gland cancer	0.000168	0.00107	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB4—EGFR—adrenal gland cancer	0.000167	0.00107	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—GNRHR—adrenal gland cancer	0.000166	0.00106	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—SDHD—adrenal gland cancer	0.000164	0.00105	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—RRM1—adrenal gland cancer	0.000164	0.00105	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—PRKACA—adrenal gland cancer	0.000162	0.00104	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00016	0.00102	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—BRAF—adrenal gland cancer	0.000159	0.00102	CbGpPWpGaD
Mesalazine—CHUK—Downstream signal transduction—EGFR—adrenal gland cancer	0.000159	0.00102	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR—EGFR—adrenal gland cancer	0.000159	0.00101	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.000158	0.00101	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB2—EGFR—adrenal gland cancer	0.000158	0.00101	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—CDC42—adrenal gland cancer	0.000158	0.00101	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—MED12—adrenal gland cancer	0.000157	0.00101	CbGpPWpGaD
Mesalazine—CHUK—DAP12 signaling—EGFR—adrenal gland cancer	0.000157	0.001	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—EGFR—adrenal gland cancer	0.000155	0.000989	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000154	0.000985	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000153	0.000977	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CDC42—adrenal gland cancer	0.000152	0.000969	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—MEN1—adrenal gland cancer	0.00015	0.000961	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—EGFR—adrenal gland cancer	0.000148	0.000944	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR in disease—EGFR—adrenal gland cancer	0.000148	0.000944	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—EGFR—adrenal gland cancer	0.000148	0.000944	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR—EGFR—adrenal gland cancer	0.000146	0.000936	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR in Cancer—EGFR—adrenal gland cancer	0.000145	0.000928	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000145	0.000926	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—EGFR—adrenal gland cancer	0.000144	0.000924	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—PRKACA—adrenal gland cancer	0.000144	0.000922	CbGpPWpGaD
Mesalazine—PTGS2—Disease—SH3KBP1—adrenal gland cancer	0.000144	0.000919	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—CDC42—adrenal gland cancer	0.000143	0.000915	CbGpPWpGaD
Mesalazine—CHUK—Disease—SPRY2—adrenal gland cancer	0.000143	0.000914	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—SDHB—adrenal gland cancer	0.000142	0.000905	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000141	0.000901	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—TP53—adrenal gland cancer	0.000141	0.0009	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00014	0.000897	CbGpPWpGaD
Mesalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—EGFR—adrenal gland cancer	0.00014	0.000897	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—EGFR—adrenal gland cancer	0.00014	0.000893	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	0.000139	0.000889	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CDC42—adrenal gland cancer	0.000137	0.000878	CbGpPWpGaD
Mesalazine—CHUK—B Cell Activation—EGFR—adrenal gland cancer	0.000137	0.000874	CbGpPWpGaD
Mesalazine—PTGS2—Disease—ZNRF3—adrenal gland cancer	0.000135	0.000864	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—EGFR—adrenal gland cancer	0.000134	0.000856	CbGpPWpGaD
Mesalazine—CHUK—Disease—MEN1—adrenal gland cancer	0.000131	0.000838	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—EGFR—adrenal gland cancer	0.000131	0.000836	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—EGFR—adrenal gland cancer	0.000124	0.000793	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—MED12—adrenal gland cancer	0.000122	0.000782	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—EGFR—adrenal gland cancer	0.000121	0.000774	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—TP53—adrenal gland cancer	0.000119	0.000763	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—TP53—adrenal gland cancer	0.000117	0.00075	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—GNAS—adrenal gland cancer	0.000117	0.000747	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	0.000117	0.000746	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—RRM1—adrenal gland cancer	0.000115	0.000735	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—SDHD—adrenal gland cancer	0.000115	0.000735	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—ABCB1—adrenal gland cancer	0.000115	0.000733	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000111	0.000712	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—BAD—adrenal gland cancer	0.00011	0.000704	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—GNRH1—adrenal gland cancer	0.00011	0.0007	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000109	0.000699	CbGpPWpGaD
Mesalazine—CHUK—Immune System—PRKACA—adrenal gland cancer	0.000108	0.000693	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—BAD—adrenal gland cancer	0.000106	0.000676	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	0.000104	0.000664	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—TP53—adrenal gland cancer	0.000102	0.00065	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—EGFR—adrenal gland cancer	0.000101	0.000643	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—SPRY2—adrenal gland cancer	0.0001	0.00064	CbGpPWpGaD
Mesalazine—CHUK—Disease—PRKACA—adrenal gland cancer	0.0001	0.00064	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—BAD—adrenal gland cancer	9.99e-05	0.000638	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—GNRH1—adrenal gland cancer	9.93e-05	0.000635	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—PRKACA—adrenal gland cancer	9.82e-05	0.000628	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TSHR—adrenal gland cancer	9.76e-05	0.000624	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—BAD—adrenal gland cancer	9.59e-05	0.000613	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CDC42—adrenal gland cancer	9.19e-05	0.000588	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—MEN1—adrenal gland cancer	9.18e-05	0.000587	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—EGFR—adrenal gland cancer	9.13e-05	0.000583	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—SDHD—adrenal gland cancer	9.12e-05	0.000583	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—RRM1—adrenal gland cancer	9.12e-05	0.000583	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—SPRY2—adrenal gland cancer	9.08e-05	0.000581	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—PRKACA—adrenal gland cancer	8.92e-05	0.000571	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TSHR—adrenal gland cancer	8.85e-05	0.000566	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—CTNNB1—adrenal gland cancer	8.74e-05	0.000559	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	8.72e-05	0.000558	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—MED12—adrenal gland cancer	8.57e-05	0.000548	CbGpPWpGaD
Mesalazine—CHUK—Disease—CDC42—adrenal gland cancer	8.49e-05	0.000542	CbGpPWpGaD
Mesalazine—PTGS2—Disease—SPRY2—adrenal gland cancer	8.47e-05	0.000542	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CDC42—adrenal gland cancer	8.33e-05	0.000533	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MEN1—adrenal gland cancer	8.32e-05	0.000532	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	8.23e-05	0.000526	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—POMC—adrenal gland cancer	7.87e-05	0.000503	CbGpPWpGaD
Mesalazine—PTGS2—Disease—MEN1—adrenal gland cancer	7.76e-05	0.000496	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	7.66e-05	0.00049	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—CTNNB1—adrenal gland cancer	7.25e-05	0.000463	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—GNAS—adrenal gland cancer	7.23e-05	0.000462	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—ABCB1—adrenal gland cancer	7.1e-05	0.000454	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—PRKACA—adrenal gland cancer	7.01e-05	0.000448	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—EGFR—adrenal gland cancer	6.92e-05	0.000443	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	6.91e-05	0.000442	CbGpPWpGaD
Mesalazine—CHUK—Disease—TERT—adrenal gland cancer	6.81e-05	0.000435	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—MED12—adrenal gland cancer	6.8e-05	0.000435	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—CTNNB1—adrenal gland cancer	6.57e-05	0.00042	CbGpPWpGaD
Mesalazine—CHUK—Immune System—BAD—adrenal gland cancer	6.41e-05	0.00041	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PRKACA—adrenal gland cancer	6.35e-05	0.000406	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—PTGS2—adrenal gland cancer	6.28e-05	0.000401	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PRKACA—adrenal gland cancer	6.25e-05	0.0004	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	6.11e-05	0.000391	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	6.08e-05	0.000389	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CDC42—adrenal gland cancer	5.94e-05	0.00038	CbGpPWpGaD
Mesalazine—PTGS2—Disease—PRKACA—adrenal gland cancer	5.93e-05	0.000379	CbGpPWpGaD
Mesalazine—CHUK—Disease—BAD—adrenal gland cancer	5.92e-05	0.000379	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—BAD—adrenal gland cancer	5.82e-05	0.000372	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—EGFR—adrenal gland cancer	5.74e-05	0.000367	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IGF2—adrenal gland cancer	5.73e-05	0.000366	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—GNAS—adrenal gland cancer	5.68e-05	0.000363	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IGF1R—adrenal gland cancer	5.54e-05	0.000354	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—EGFR—adrenal gland cancer	5.51e-05	0.000352	CbGpPWpGaD
Mesalazine—CHUK—Disease—BRAF—adrenal gland cancer	5.39e-05	0.000345	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CDC42—adrenal gland cancer	5.39e-05	0.000344	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—EGFR—adrenal gland cancer	5.2e-05	0.000333	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IGF2—adrenal gland cancer	5.19e-05	0.000332	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—GNAS—adrenal gland cancer	5.15e-05	0.000329	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GNAS—adrenal gland cancer	5.07e-05	0.000324	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CDC42—adrenal gland cancer	5.03e-05	0.000321	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IGF1R—adrenal gland cancer	5.02e-05	0.000321	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—EGFR—adrenal gland cancer	5e-05	0.00032	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—ABCB1—adrenal gland cancer	4.97e-05	0.000318	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PRKACA—adrenal gland cancer	4.96e-05	0.000317	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—POMC—adrenal gland cancer	4.87e-05	0.000311	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TERT—adrenal gland cancer	4.77e-05	0.000305	CbGpPWpGaD
Mesalazine—CHUK—Disease—PTGS2—adrenal gland cancer	4.35e-05	0.000278	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TERT—adrenal gland cancer	4.32e-05	0.000276	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CTNNB1—adrenal gland cancer	4.22e-05	0.00027	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—BAD—adrenal gland cancer	4.15e-05	0.000265	CbGpPWpGaD
Mesalazine—PTGS2—Disease—TERT—adrenal gland cancer	4.03e-05	0.000258	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GNAS—adrenal gland cancer	4.02e-05	0.000257	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ABCB1—adrenal gland cancer	3.95e-05	0.000252	CbGpPWpGaD
Mesalazine—CHUK—Disease—CTNNB1—adrenal gland cancer	3.9e-05	0.000249	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—PTGS2—adrenal gland cancer	3.88e-05	0.000248	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CTNNB1—adrenal gland cancer	3.83e-05	0.000245	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—POMC—adrenal gland cancer	3.82e-05	0.000244	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—BRAF—adrenal gland cancer	3.78e-05	0.000241	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—BAD—adrenal gland cancer	3.76e-05	0.00024	CbGpPWpGaD
Mesalazine—PTGS2—Disease—BAD—adrenal gland cancer	3.51e-05	0.000224	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—POMC—adrenal gland cancer	3.47e-05	0.000222	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—BRAF—adrenal gland cancer	3.42e-05	0.000219	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—POMC—adrenal gland cancer	3.41e-05	0.000218	CbGpPWpGaD
Mesalazine—CHUK—Immune System—EGFR—adrenal gland cancer	3.34e-05	0.000214	CbGpPWpGaD
Mesalazine—PTGS2—Disease—BRAF—adrenal gland cancer	3.19e-05	0.000204	CbGpPWpGaD
Mesalazine—CHUK—Disease—EGFR—adrenal gland cancer	3.09e-05	0.000197	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—EGFR—adrenal gland cancer	3.03e-05	0.000194	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CTNNB1—adrenal gland cancer	2.73e-05	0.000174	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PTGS2—adrenal gland cancer	2.72e-05	0.000174	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—POMC—adrenal gland cancer	2.71e-05	0.000173	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CTNNB1—adrenal gland cancer	2.47e-05	0.000158	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CTNNB1—adrenal gland cancer	2.31e-05	0.000148	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—EGFR—adrenal gland cancer	2.16e-05	0.000138	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—EGFR—adrenal gland cancer	1.96e-05	0.000125	CbGpPWpGaD
Mesalazine—PTGS2—Disease—EGFR—adrenal gland cancer	1.83e-05	0.000117	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TP53—adrenal gland cancer	1.81e-05	0.000116	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TP53—adrenal gland cancer	1.65e-05	0.000105	CbGpPWpGaD
